Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Authors
Keywords
-
Journal
LIVER INTERNATIONAL
Volume 37, Issue 8, Pages 1122-1127
Publisher
Wiley
Online
2017-04-20
DOI
10.1111/liv.13456
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A meta-analysis of single HCV-untreated arm of studies evaluating outcomes after curative treatments of HCV-related hepatocellular carcinoma
- (2017) Giuseppe Cabibbo et al. LIVER INTERNATIONAL
- Clinical Outcomes in HCV-Infected Patients Treated with Direct Acting Antivirals - 18 Month Post-Treatment Follow-Up in the French ANRS CO22 Hepather Cohort Study
- (2016) F. Carrat JOURNAL OF HEPATOLOGY
- Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
- (2016) Fabio Conti et al. JOURNAL OF HEPATOLOGY
- Direct antiviral agents and risk for HCC early recurrence: Much ado about nothing
- (2016) Calogero Cammà et al. JOURNAL OF HEPATOLOGY
- Unexpected high incidence of hepatocellular carcinoma in cirrhotic patients with sustained virologic response following interferon-free direct-acting antiviral treatment
- (2016) Karin Kozbial et al. JOURNAL OF HEPATOLOGY
- Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
- (2016) María Reig et al. JOURNAL OF HEPATOLOGY
- Lack of evidence of an effect of direct-acting antivirals on the recurrence of hepatocellular carcinoma: Data from three ANRS cohorts
- (2016) JOURNAL OF HEPATOLOGY
- Hepatitis C virus treatment in the real world: optimising treatment and access to therapies: Table 1
- (2015) Fabien Zoulim et al. GUT
- Complications and competing risks of death in compensated viral cirrhosis (ANRS CO12 CirVir prospective cohort)
- (2015) Jean-Claude Trinchet et al. HEPATOLOGY
- EASL Recommendations on Treatment of Hepatitis C 2015
- (2015) JOURNAL OF HEPATOLOGY
- Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
- (2015) Jordi Bruix et al. LANCET ONCOLOGY
- Life Expectancy in Patients With Chronic HCV Infection and Cirrhosis Compared With a General Population
- (2014) Adriaan J. van der Meer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
- (2013) Rebecca L. Morgan et al. ANNALS OF INTERNAL MEDICINE
- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started